Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H23NO2 |
Molecular Weight | 273.37 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C3=CC(C)=CC(C)=C3
InChI
InChIKey=HDDNYFLPWFSBLN-ZSHCYNCHSA-N
InChI=1S/C17H23NO2/c1-11-6-12(2)8-13(7-11)17(19)20-16-9-14-4-5-15(10-16)18(14)3/h6-8,14-16H,4-5,9-10H2,1-3H3/t14-,15+,16+
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
5HT2 and 5HT3 receptors' contribution to modeling of post-serotonin respiratory pattern in cats. | 2004 Sep 24 |
|
GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice. | 2010 Apr |
|
5-HT3 receptor-dependent modulation of respiratory burst frequency, regularity, and episodicity in isolated adult turtle brainstems. | 2010 Jun 30 |
|
Analgesia induced by 2- or 100-Hz electroacupuncture in the rat tail-flick test depends on the anterior pretectal nucleus. | 2013 Nov 6 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3893732
Forty-seven patients with common (n = 29) or classical (n = 8) migraine or mixed type with or without a psychogenic component (n = 10) received 20-40 mg Tropanserin (MDL-72,422) (n = 24) or placebo (n = 23) intravenously during the headache phase of a migraine attack.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18718451
Treatment of rat ganglia with the 5-HT(3) receptor antagonist Tropanserin (MDL 72222) (0.5 uM) during the maintenance phase of established gLTD (1 h after LFS) antagonized the LFS-induced depression.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66885
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID0042618
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
64142
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
85181-40-4
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL1742402
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
SUB11338MIG
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
100000076958
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
C95218
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
5882
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY | |||
|
04B48I6VHR
Created by
admin on Fri Dec 15 18:30:14 GMT 2023 , Edited by admin on Fri Dec 15 18:30:14 GMT 2023
|
PRIMARY |
ACTIVE MOIETY